These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Lung involvement in Hodgkin's disease. Study of 49 cases. II. Diagnosis. Differential diagnosis. Association with other diseases]. Puras Tellaeche A; Frieyro Segui JE Rev Clin Esp; 1982 Mar; 164(5):285-91. PubMed ID: 7100541 [No Abstract] [Full Text] [Related]
6. [Non-Hodgkin lymphoma associated with a relapse of Hodgkin's disease]. Tertian G; Louvel A; Picard F; Varet B Nouv Rev Fr Hematol (1978); 1983; 25(6):375-8. PubMed ID: 6664835 [TBL] [Abstract][Full Text] [Related]
7. Hodgkin's disease of the oesophagus: a literature review. Jones K; Pacella J; Wasty F Australas Radiol; 2007 Oct; 51(5):489-91. PubMed ID: 17803804 [TBL] [Abstract][Full Text] [Related]
14. [Late complications after treatment of Hodgkin's disease]. Lund MB; Kongerud J; Boe J; Ihlen H; Forfang K; Abrahamsen AF; Nome O Tidsskr Nor Laegeforen; 1999 Mar; 119(7):933-7. PubMed ID: 10210953 [TBL] [Abstract][Full Text] [Related]
15. Coexistence of Hodgkin's disease and giant lymph node hyperplasia of the plasma-cell type (Castleman's disease). Abdel-Reheim FA; Koss W; Rappaport ES; Arber DA Arch Pathol Lab Med; 1996 Jan; 120(1):91-6. PubMed ID: 8554455 [TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group. Meyer RM; Gospodarowicz MK; Connors JM; Pearcey RG; Bezjak A; Wells WA; Burns BF; Winter JN; Horning SJ; Dar AR; Djurfeldt MS; Ding K; Shepherd LE; ; J Clin Oncol; 2005 Jul; 23(21):4634-42. PubMed ID: 15837968 [TBL] [Abstract][Full Text] [Related]
17. [Selected problems of etiopathogenesis, clinical aspects and treatment of Hodgkin's disease in children]. Ochocka M; Ciepielewska D Pol Tyg Lek; 1983 Oct 17-24; 38(42-43):1297-300. PubMed ID: 6674953 [No Abstract] [Full Text] [Related]
18. High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes. Wheeler C; Eickhoff C; Elias A; Ibrahim J; Ayash L; McCauley M; Mauch P; Schwartz G; Eder JP; Mazanet R; Ferrara J; Rimm IJ; Guinan E; Bierer B; Gilliland G; Churchill WH; Ault K; Parsons S; Antman K; Schnipper L; Tepler I; Gaynes L; Frei E; Kadin M; Antin J Biol Blood Marrow Transplant; 1997 Jun; 3(2):98-106. PubMed ID: 9267670 [TBL] [Abstract][Full Text] [Related]
19. [Management of Hodgkin's disease]. Lahtinen R; Elonen E Duodecim; 1989; 105(11):1056-65. PubMed ID: 2666089 [No Abstract] [Full Text] [Related]
20. [Critical considerations on the present approach to Hodgkin's disease]. Neretto G; Sabbaa S; Poccardi G; Giovanelli E Minerva Med; 1983 Oct; 74(38):2197-201. PubMed ID: 6646470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]